Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 1, 2007 - Issue 2
Submit an article Journal homepage
408
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Research into lung disease: a call for urgent action

Stephen T Holgate Medical Research Council Professor of Immunopharmacology, University of Southampton, School of Medicine, SO16 6YD, UK. [email protected]
Pages 177-181 | Published online: 09 Jan 2014

References

  • Snell WE. The British Thoracic Association: the First Fifty Years. British Thoracic Association. London, UK (1978).
  • Davies PD. TB at the end of the 20th century. Thorax56(11), 897 (2001).
  • Vynnycky E, Fine PE. Interpreting the decline in tuberculosis: the role of secular trends in effective contact. Int. J. Epidemiol.28(2), 327–334 (1999).
  • Davies RP, Tocque K, Bellis MA, Rimmington T, Davies PD. Historical declines in tuberculosis in England and Wales: improving social conditions or natural selection? Int. J. Tuberc. Lung Dis.3(12), 1051–1054 (1999).
  • Davies PD. Tuberculosis and migration. The Mitchell Lecture 1994. J. R. Coll. Physicians Lond.29(2), 113–118 (1995).
  • Karlson AG, Feldman WH. The use of guinea pigs in studying chemotherapy of experimental tuberculosis. Ann. NY Acad. Sci.52(5), 637–645 (1949).
  • Karlson AG, Gainer JH, Feldman WH. The effect of dihydrostreptomycin para-aminosalicylate on experimental tuberculosis in guinea pigs. Am. Rev. Tuberc.62(2), 149–155 (1950).
  • Smith HV, Vollum RL. Effects of intrathecal tuberculin and streptomycin in tuberculous meningitis; an interim report. Lancet2(8), 275–286 (1950).
  • Pfuetze KH, Pyle MM, Hinshaw HC, Feldman WH. The first clinical trial of streptomycin in human tuberculosis. Am. Rev. Tuberc.71(5), 752–754 (1955).
  • Feldman WH. Streptomycin: some historical aspects of its development as a chemotherapeutic agent in tuberculosis. Am. Rev. Tuberc.89(6), 859–868 (1954).
  • Sabin AB. Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA194(8), 872–876 (1965).
  • Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br. Med. J.2(4682), 739–748 (1950).
  • White C. Research on smoking and lung cancer: a landmark in the history of chronic disease epidemiology. Yale J. Biol. Med.63(1), 29–46 (1990).
  • Abercrombie GF. December fog in London and the emergency bed service. Lancet1(5), 234–235 (1953).
  • Waller RE, Lawther PJ. London fog. Science161(836), 6–7 (1968).
  • Stocks P. On the death rates from cancer of the stomach and respiratory diseases in 1949–53 among coal miners and other male residents in counties of England and Wales. Br. J. Cancer16, 592–598 (1962).
  • Cochrane AL, Thomas J. Changes in the prevalence of coalworkers’ pneumoconiosis among miners and ex-miners in the Rhondda Fach 1951–61. Br. J. Ind. Med.22, 49–57 (1965).
  • Acheson ED, Gardner MJ. Mesothelioma and exposure to mixtures of chrysotile and amphibole asbestos. Arch. Environ. Health34(4), 240–242 (1979).
  • Ahlquist RP. Development of the concept of α and β adrenotropic receptors. Ann. NY Acad. Sci.139(3), 549–552 (1967).
  • Brittain RT, Jack D, Ritchie AC. Recent β-adrenoreceptor stimulants. Adv. Drug Res.5, 197–253 (1970).
  • Brown HM, Storey G, George WH. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br. Med. J.1(5800), 585–590 (1972).
  • Milne L. The British Thoracic Association. 50th Anniversary Meeting held at Bournemouth on 19–22 April 1978. Abstracts of papers presented. Br. J. Dis. Chest72(3), 253–262 (1978).
  • Turner-Warwick M. The British Thoracic Society. Thorax37(5), 321–323 (1982).
  • UKCRC. UK Health Research Analysis. UKCRC, UK (2006).
  • British Lung Foundation. Lung Report III: Casting a Shadow Over the Nation’s Health. BLF, UK (2005).
  • British Lung Foundation. Lost in Translation: Bridging the Communication Gap in COPD. BLF, UK (2006).
  • British Lung Foundation. 20 Years of BLF Research. BLF, UK (2006).
  • Baselga J, Averbuch SD. ZD1839 (‘Iressa’) as an anticancer agent. Drugs60(Suppl. 1), 33–40 (2000).
  • Holgate ST. Priorities for respiratory research in the UK. Thorax62(1), 5–7 (2007).
  • Green M. The British Lung Foundation. Br. J. Dis. Chest82(2), 105–110 (1988).
  • MacNee W, Walden IM. Lung research funding in the UK: the British Lung Foundation perspective. Thorax53(4), 239–240 (1998).
  • Cooksey D. A review of UK health research funding. A Report for HM Treasury. Her Majesty’s Stationery Office, UK (2006).

Websites

  • British Thoracic Society. The burden of lung disease BTS www.brit-thoracic.org.uk/BurdenofLung Disease2.html
  • Asthma UK. Where next in clinical asthma research? An Asthma UK consultation on clinical asthma research strategy www.asthma.org.uk/document.rm?id=23
  • Asthma UK. Where next in basic asthma research? www.asthma.org.uk/document.rm?id=128

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.